Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $138.4500 (2.97%) ($134.1000 - $138.6000) on Thu. Sep. 1, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.37% (three month average) | RSI | 36 | Latest Price | $138.4500(2.97%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.1% a day on average for past five trading days. | Weekly Trend | ABBV declines -2.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(33%) DIA(27%) SPLV(25%) VYM(24%) XLP(24%) | Factors Impacting ABBV price | ABBV will decline at least -0.685% in a week (0% probabilities). VIXM(-16%) UUP(-14%) TBT(-3%) UNG(-1%) VXX(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.685% (StdDev 1.37%) | Hourly BBV | 1.6 () | Intraday Trend | 2.8% | | | |
|
1 - 5 Day Possible Target | $133.8(-3.36%) | Resistance Level | $139.44 | 5 Day Moving Average | $136.1(1.73%) | 10 Day Moving Average | $137.79(0.48%) | 20 Day Moving Average | $139.44(-0.71%) | To recent high | -10.2% | To recent low | 3% | Market Cap | $244.265b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |